News and Events

  • Complimentary Webinar – Nothing but NETs: Unraveling biomarkers for NETosis research

    Posted: January 3, 2024

    It’s Not Just Support. It’s Solutions. Register today for Nothing but NETs: Unraveling biomarkers for NETosis research A webinar aimed to examine widely used biomarkers of NETosis, and understanding how they can best used to paint a complete picture of relevant events in disease. This presentation hopes to highlight commonly used assays, while introducing Volition’s…

    Read More

  • Do We Need To Standardize Coagulation Nomenclature In Today’s Laboratory Environment?

    Posted: December 21, 2023

    David L. McGlasson, MS, MLS(ASCP) A few months ago, I posted on LinkedIn that I noticed at recent conferences and journal articles that blood coagulation factors were sometimes referred to in Euro-Arabic numbers (E-A), 0 through 9, instead of Roman numerals.For example, “F8” was written instead of “FVIII”.And sometimes they are used interchangeably. I received…

    Read More

  • Out with the Fatty Liver… In with the New Nomenclature

    Posted: October 24, 2023

    -Contributed by Abi Kasberg, PhD Changes have arrived to the field of hepatic steatosis! In efforts to destigmatize and enhance the identification of steatotic liver diseases, several worldwide governing bodies (AASLD, EASL, and ALEH) recently came together to form a multi-stage Delphi panel that assessed, edited, and published changes to the standard nomenclature and diagnostic…

    Read More

  • The standardization of NET measurements, a work in progress.

    Posted: October 5, 2023

    -Contributed by Abi Kasberg, PhD and Olivia Stricker, PhD   Neutrophil extracellular traps (NETs) are an amazing participant of the innate immune system. In a first line of defense, neutrophils expel decondensated chromatin into the extracellular matrix to trap invading pathogens in a mechanism called NETosis. NETs are made up of DNA, histones, and granule…

    Read More

  • What’s New at DiaPharma? Ted Lasso said it best…

    Posted: September 27, 2023

    It’s Not Just Support. It’s Solutions. TEST Our Commitment to Be Curious DiaPharma held our semiannual company-wide meeting this summer. On the work side, we channeled Ted Lasso in our commitment to be curious. We reaffirmed who we are: scientific support, solutions-based sales, accommodating customer service, and common-sense operations. One DiaPharma team, working together, to…

    Read More

  • Highest Quality Assays for IVIG and Albumin Safety Testing

    Posted: September 12, 2023

    Reliable testing for procoagulant contaminants To reduce the risk of thromboembolic events, manufacturers need reliable assays to test procoagulant contaminants in IVIG and Albumin preparations. DiaPharma offers a variety of products for sensitive quality control and safety testing for detection of potential thrombogenic activity. Prekallikrein Activity Assays Specialty Range of PKA Assay Kits, Reagents &…

    Read More

  • Comprehensive Solutions for von Willebrand Disease Research

    Posted: September 11, 2023

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your von Willebrand Disease Research Reagent-complete kits for vWF Activity, Antigen, Collagen Binding, Propeptide, and more. FEATURED PRODUCTS Technozym vWF:CBA* Collagen Binding ELISA Ask your Territory Manager about a free evaluation kit through September! Inter Array vWF:pp* Standardized Propeptide ELISA Ready-to-use complete kit…

    Read More

  • A Review of the XXXVth International Symposium on Technical Innovations in Laboratory Hematology 2023 (ISLH 2023)

    Posted: September 8, 2023

    David L. McGlasson, MS, MLS(ASCP) The most recent ISLH meeting was held in New Orleans, LA May 11-13, 2023.  The conference had many State-of-the-Art sessions and I concentrated on the hemostasis/thrombosis presentations. On the first day, Katrien Devreese MD, PhD, Ghent University Hospital, Belgium gave an excellent presentation on the current Diagnosis of Acquired Thrombotic…

    Read More

  • Comprehensive Solutions for Your Fibrinolysis Research

    Posted: September 7, 2023

    It’s Not Just Support. It’s Solutions.   Fibrinolysis Assays from DiaPharma that will enhance your research Whether you’re researching basic fibrinolysis mechanisms or investigating new potential thrombolytics, you need reliable, relevant tests. DiaPharma can help you select the right assays. Featured Products: Technoclone tPA Purified Protein Single chain tissue type plasminogen activator (human, recombinant),with activity…

    Read More

  • Comprehensive Solutions for Anticoagulation Research

    Posted: August 15, 2023

    It’s Not Just Support. It’s Solutions. Explore Assays from DiaPharma to Enhance Your Anticoagulation Research Whether you’re researching vitamin K antagonists, thrombin inhibitors, FXa inhibitors, or contact pathway inhibitors, you need reliable, relevant tests. DiaPharma can help you select the right assays. DOAC-STOP™ Tablets* THE original DOAC eliminator Don’t be fooled by copies – DOAC-STOP™…

    Read More

  • Nothing but NETs…Introductory pricing for Nu.Q® Discover H3.1 ELISA Research Use Only Kit

    Posted: August 2, 2023

    It’s Not Just Support. It’s Solutions. DiaPharma now offers the Volition Nu.Q® Discover H3.1 ELISA DiaPharma is excited to announce a new relationship with VolitionRx Ltd to provide the Nu.Q® Discover H3.1 ELISA in the U.S. and Canada. Volition’s Nu.Q® Discover H3.1 ELISA Research Use Only kit detects quantitative levels of circulating intact nucleosomes containing…

    Read More

  • Don’t Miss Out – Complimentary Webinar on Neutrophils in Sputum: Why Give a Spit?

    Posted: July 11, 2023

    It’s Not Just Support. It’s Solutions.   It’s Almost Here! Neutrophils in Sputum: Why Give a Spit? Wednesday, July 12 at 11 a.m. EDT Please join DiaPharma for a complimentary educational webinar on the benefits of using sputum samples to take an accurate picture of neutrophil-driven immune responses in the lung. Speaker Neil Alexis, Ph.D.…

    Read More

  • Relevant topic in a time of wildfire smoke: Neutrophils in Sputum – Webinar July 12th

    Posted: July 5, 2023

    It’s Not Just Support. It’s Solutions. Complimentary Webinar Neutrophils in Sputum: Why Give a Spit? Wednesday, July 12 at 11 a.m. EDT Over this past week, many of us in the Midwest and East are experiencing terribly low air quality due to the Canadian wildfires. A webinar on assessing neutrophil activity in the lung therefore…

    Read More

  • DiaPharma Celebrates hae day 🙂

    Posted: May 15, 2023

    It’s Not Just Support. It’s Solutions. May 16 is hae day 🙂 Join DiaPharma in raising awareness, step by step The annual hae day 🙂 aims to raise awareness worldwide of HAE. Team DiaPharma is getting #Active4HAE! Join us by logging time spent on physical or well-being activities at haeday.org. Read about emerging therapeutic targets…

    Read More

  • Collagen is tough (pun intended), make your life easier with these QuickZyme kits

    Posted: May 4, 2023

    It’s Not Just Support. It’s Solutions.   DiaPharma and QuickZyme Know Matrix Matters! For tissues with lower collagen levels and high matrix effect, analyzing collagen is difficult. QuickZyme therefore developed an assay in which the matrix effect was neutralized to make total collagen analysis suited for more organs or imbedded tissue. The references below are…

    Read More

  • Are your patients getting the proper level of anticoagulation?

    Posted: April 28, 2023

    It’s Not Just Support. It’s Solutions. Measuring Warfarin in Patients with a Lupus Anticoagulant At the recent HTRS 2023 Scientific Symposium, a lively discussion in a Plenary Session was presented titled, “Do We Dare to DOAC?” in which presenters debated the use of DOACs in patients with antiphospholipid antibody syndrome (aPS). For an in-depth review,…

    Read More

  • Why isn’t this being funded?! Product Grant Opportunity from DiaPharma

    Posted: April 28, 2023

    It’s Not Just Support. It’s Solutions. Thoughts from HTRS 2023, and a Grant Opportunity The HTRS 2023 Scientific Symposium gave new insights in hemostasis and thrombosis, from health justice initiatives to the latest in antiphospholipid antibody testing. One thing that stood out was a focus on bleeding and clotting disorders in special populations such as…

    Read More

  • Anticipated NASH Drug Approval will Require Expanded Non-Invasive Testing: NASH-TAG 2023 Takeaways

    Posted: April 19, 2023

    -Contributed by Abi Kasberg, PhD High levels of enthusiasm and excitement were shared at this year’s NASH-TAG meeting in Deer Valley, Utah, regarding the future of the NASH landscape. This was in large part due to the announcement of positive data from two phase 3 clinical trials for new NASH drugs: Madrigal’s Resmetirom and Intercept’s…

    Read More

  • SOT 2023, Recap through a DiaPharma lens

    Posted: April 19, 2023

    -Olivia Stricker, PhD Meetings are back baby!  This was the first event that I have been to since the pandemic where it felt 100% back to normal.  It was great to get back to it and have others there to get back to it with. In heading to Nashville, DiaPharma/I was in search of answers…

    Read More

  • Should Direct Oral Anticoagulants (DOAC) be Used in Individuals with Antiphospholipid Syndrome (aPS) vs Long Term Warfarin Treatment?

    Posted: April 14, 2023

    David L. McGlasson, MS, MLS(ASCP) At the recent HTRS 2023 Scientific Symposium, a lively discussion in a Plenary Session was presented titled, “Do We Dare to DOAC?” The HTRS session was moderated by Ayesha N. Zia MD, MSCS and Bethany T. Samuelson, MD, and included three presenters: Introduction to Science: Stephan Moll, MD, University of…

    Read More